Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Space & Other Races

  |  Issue: October 2020  |  

Dr. SeoPhilip Seo, MD, MHS, is an associate professor of medicine at the Johns Hopkins University School of Medicine, Baltimore. He is director of both the Johns Hopkins Vasculitis Center and the Johns Hopkins Rheumatology Fellowship Program.

References

  1. Rockets, radar, and computers: The International Geophysical Year. NOAA celebrates 200 years of science, service, and stewardship. National Ocean Service, National Oceanic and Atmospheric Administration, U.S. Department of Commerce. 2017 May 12.
  2. Wallace T. How Sputnik 1 launched the space age. Cosmos Magazine. 2017 Oct 3.
  3. Sputnik V: What we know about Russia’s coronavirus vaccine. Aljazeera. 2020 Aug 13.
  4. Phases of clinical trials. National Comprehensive Cancer Network.
  5. Hong CH, Siah KW, Lo AW. Estimation of clinical trial success rates and related parameters. Biostatistics. 2019 Apr;20(2):273–286.
  6. Moore TJ, Zhang H, Anderson G, et al. Estimated costs of pivotal trials for novel therapeutic agents approved by the US Food and Drug Administration 2015–2016. JAMA Intern Med. 2018 Mov 1;178(11):1451–1457.
  7. Sullivan T. A tough road: Cost to develop one new drug is $2.6 billion; approval rate for drugs entering clinical development is less than 12%. Policy & Medicine. 2019 Mar 21.
  8. Theuretzbacher U. Recent FDA antibiotic approvals: Good news and bad news. The Center for Disease Dynamics, Economics & Policy. 2015 Mar 12.
  9. Steckelberg A, Johnson CY, Florit G, Alcantara C. These are the top coronavirus vaccines to watch. The Washington Post. 2020 Aug 24 (updated Sep 8).
  10. Akpan N. Fauci “seriously doubts” the Russia vaccine is ready for widespread use. National Geographic. 2020 Aug 11.
  11. Aronczyk A, Gonzalez S. Where’s the vaccine? NPR. 2020 Mar 6.
  12. Pandemic influenza vaccine manufacturing process and timeline. Pandemic (H1N1) 2009 briefing note 7. World Health Organization. 2009 Aug 6.
  13. Restifo NP, Ying H, Hwang L, Leitner WW. The promise of nucleic acid vaccines. Gene Ther. 2000 Jan;7(2):89–92.
  14. Ura T, Okuda K, Shimada M. Developments in viral vector-based vaccines. Vaccines (Basel). 2014 Sep;2(3);624–641.
  15. Nigrovic LE, Thompson KM. Epidemiol Infect. 2007 Jan;135(1):1–8.
  16. Kennedy JF. John F. Kennedy moon speech—Rice Stadium. 1962 Sep 12.
  17. O’Keefe SM. One in three Americans would not get COVID-19 vaccine. Gallup. 2020 Aug 7.
  18. D’Souza G, Dowdy D. What is herd immunity and how can we achieve it with COVID-19? Johns Hopkins. COVID-19 School of Public Health Expert Insights. 2020 Apr 10.
  19. Sullivan P. Azar on Russia vaccine claim: Point is to be ‘safe and effective.’ The Hill. 2020 Aug 11.

Related Articles
    ACR Convergence 2020

    ACR Convergence 2020: Progress Toward COVID-19 Vaccines

    ACR CONVERGENCE 2020—A scientific session on Sunday, Nov. 8, focused on vaccine prospects in COVID-19. Dan Barouch, MD, PhD, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center and the William Bosworth Castle Professor of Medicine at Harvard Medical School in Boston, shared his insights about vaccine development across…

    Vax Hesitancy? Myths & Facts for Patients

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    Anze Furlan / SHUTTERSTOCK.COM

    How Immunosuppression May Affect COVID-19 Vaccine Response

    Although we can expect to learn much more, preliminary data are now available on the potential safety and effectiveness of COVID-19 vaccines in rheumatology patients. The picture is likely to be nuanced, with not all types of immuno­suppressive treatments having identical impacts on vaccine response. Rheumatologists should use caution in interpreting early reports, while continuing…